Neuronal nitric oxide inhibits intestinal smooth muscle growth

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 298, Issue 6, 2010, Pages

  Pelletier, Anne Marie ^a   Venkataramana, Shriram ^a   Miller, Kurtis G ^b   Bennett, Brian M ^a   Nair, Dileep G ^a   Lourenssen, Sandra ^a   Blennerhassett, Michael G ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b Queen's University ^*

Author keywords

cAMP; cGMP; Colitis; Growth inhibition; Intestine nitric oxide; Neuronal nitric oxide synthase

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 7 NITROINDAZOLE; 8 BROMO CYCLIC GMP; BROXURIDINE; CILOSTAMIDE; CYCLIC AMP; CYCLIC GMP; N [(4) 4 AMINO 5 [2 AMINOETHYL](AMINO)PENTYL] N' NITROGUANIDINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; THYMIDINE; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG; ZAPRINAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CAMP NURSING; CELL GROWTH; COCULTURE; COLITIS; COLON; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FETAL CALF SERUM; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE INNERVATION; INTESTINE MUSCLE; MALE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; STIMULUS RESPONSE;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; COLITIS; CYCLIC GMP; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTESTINES; MALE; MYENTERIC PLEXUS; MYOCYTES, SMOOTH MUSCLE; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; RATS; RATS, SPRAGUE-DAWLEY; TRINITROBENZENESULFONIC ACID;

EID: 77952720685     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00259.2009     Document Type: Article

References (46)

1. Ahanchi SS, Tsihlis ND, Kibbe MR. The role of nitric oxide in the pathophysiology of intimal hyperplasia. J Vasc Surg 45, Suppl A: A64-A73, 2007.
2. Anderson PG, Boerth NJ, Liu M, McNamara DB, Cornwell TL, Lincoln TM. Cyclic GMP-dependent protein kinase expression in coronary arterial smooth muscle in response to balloon catheter injury. Arterioscler Thromb Vasc Biol 20: 2192-2197, 2000.
3. Beck PL, Xavier R, Wong J, Ezedi I, Mashimo H, Mizoguchi A, Mizoguchi E, Bhan AK, Podolsky DK. Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am J Physiol Gastrointest Liver Physiol 286: G137-G147, 2004.
4. Beierwaltes WH. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3. Am J Physiol Renal Physiol 290: F1376-F1381, 2006.
5. Bland-Ward PA, Moore PK. 7-Nitro indazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase. Life Sci 57: L131-L135, 1995.
6. Blennerhassett MG, Lourenssen S. Neural regulation of intestinal smooth muscle growth in vitro. Am J Physiol Gastrointest Liver Physiol 279: G511-G519, 2000.
7. Blennerhassett MG, Vignjevic P, Vermillion DL, Collins SM. Inflammation causes hyperplasia and hypertrophy in smooth muscle of rat small intestine. Am J Physiol Gastrointest Liver Physiol 262: G1041-G1046, 1992.
8. Boerrigter G, Burnett JC Jr. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease. Cardiovasc Drug Rev 25: 30-45, 2007. (Pubitemid 46625289)
9. Brehmer A, Schrodl F, Neuhuber W. Morphology of VIP/nNOS-immunoreactive myenteric neurons in the human gut. Histochem Cell Biol 125: 557-565, 2006. (Pubitemid 43673518)
10. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275: 87-90, 1990. (Pubitemid 20386182)
11. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol Cell Physiol 267: C1405-C1413, 1994. (Pubitemid 2163839)
12. De Man JG, De Winter BY, Herman AG, Pelckmans PA. Study on the cyclic GMP-dependency of relaxations to endogenous and exogenous nitric oxide in the mouse gastrointestinal tract. Br J Pharmacol 150: 88-96, 2007.
13. Depoortere I, Thijs T, Peeters TL. Generalized loss of inhibitory innervation reverses serotonergic inhibition into excitation in a rabbit model of TNBS-colitis. Br J Pharmacol 135: 2011-2019, 2002. (Pubitemid 34478314)
14. Dohi T, Fujihashi K. Type 1 and 2 T helper cell-mediated colitis. Curr Opin Gastroenterol 22: 651-657, 2006.
15. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206: 260-276, 2005. (Pubitemid 41105175)
16. Hah JM, Roman LJ, Martasek P, Silverman RB. Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N′- nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase. J Med Chem 44: 2667-2670, 2001. (Pubitemid 32852155)
17. Hamad AM, Johnson SR, Knox AJ. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 277: L910-L918, 1999.
18. Hogaboam CM, Jacobson K, Collins SM, Blennerhassett MG. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol Gastrointest Liver Physiol 268: G673-G684, 1995.
19. Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 92: 1-20, 2001. (Pubitemid 34032020)
20. Kono T, Chisato N, Ebisawa Y, Asama T, Sugawara M, Ayabe T, Kohgo Y, Kasai S, Yoneda M, Takahashi T. Impaired nitric oxide production of the myenteric plexus in colitis detected by a new bioimaging system. J Surg Res 117: 329-338, 2004. (Pubitemid 38393659)
21. Kuemmerle JF, Zhou H, Bowers JG. IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins. Am J Physiol Gastrointest Liver Physiol 286: G412-G419, 2004. (Pubitemid 38250313)
22. Lourenssen S, Wells RW, Blennerhassett MG. Differential responses of intrinsic and extrinsic innervation of smooth muscle cells in rat colitis. Exp Neurol 195: 497-507, 2005. (Pubitemid 41297800)
23. Lourenssen SR, Miller KG, Blennerhassett MG. Discrete responses of myenteric neurons to structural and functional damage by neurotoxins in vitro. Am J Physiol Gastrointest Liver Physiol 297: G228-G239, 2009.
24. Makhlouf GM, Murthy KS. Signal transduction in gastrointestinal smooth muscle. Cell Signal 9: 269-276, 1997. (Pubitemid 27271647)
25. Marlow SL, Blennerhassett MG. Deficient innervation characterizes intestinal strictures in a rat model of colitis. Exp Mol Pathol 80: 54-66, 2006.
26. Maurice DH, Haslam RJ. Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle. Eur J Pharmacol 191: 471-475, 1990.
27. Mizuta Y, Isomoto H, Takahashi T. Impaired nitrergic innervation in rat colitis induced by dextran sulfate sodium. Gastroenterology 118: 714-723, 2000. (Pubitemid 30171621)
28. Moncada S, Higgs EA. Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 176: 213-254, 2006.
29. Morrow D, Guha S, Sweeney C, Birney Y, Walshe T, O'Brien C, Walls D, Redmond EM, Cahill PA. Notch and vascular smooth muscle cell phenotype. Circ Res 103: 1370-1382, 2008.
30. Ohama T, Hori M, Momotani E, Elorza M, Gerthoffer WT, Ozaki H. IL-1β inhibits intestinal smooth muscle proliferation in an organ culture system: involvement of COX-2 and iNOS induction in muscularis resident macrophages. Am J Physiol Gastrointest Liver Physiol 292: G1315-G1322, 2007. (Pubitemid 47084662)
31. Ohlsson B, Veress B, Lindgren S, Sundkvist G. Enteric ganglioneuritis and abnormal interstitial cells of Cajal: features of inflammatory bowel disease. Inflamm Bowel Dis 13: 721-726, 2007. (Pubitemid 46909986)
32. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801, 2004. (Pubitemid 38823766)
33. Porras M, Martin MT, Torres R, Vergara P. Cyclical upregulated iNOS and long-term downregulated nNOS are the bases for relapse and quiescent phases in a rat model of IBD. Am J Physiol Gastrointest Liver Physiol 290: G423-G430, 2006.
34. Sanovic S, Lamb DP, Blennerhassett MG. Damage to the enteric nervous system in experimental colitis. Am J Pathol 155: 1051-1057, 1999. (Pubitemid 29488912)
35. Sayed N, Baskaran P, Ma X, van den Akker F, Beuve A. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA 104: 12312-12317, 2007. (Pubitemid 47206134)
36. Sharif F, Hynes SO, Cooney R, Howard L, McMahon J, Daly K, Crowley J, Barry F, O'Brien T. Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. Mol Ther 16: 1674-1680, 2008.
37. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78: 539-552, 2009.
38. Stehlik J, Movsesian MA. Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure. Expert Opin Investig Drugs 15: 733-742, 2006.
39. Tanaka K, Zou JP, Takeda K, Ferrans VJ, Sandford GR, Johnson TM, Finkel T, Epstein SE. Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation 99: 1656-1659, 1999. (Pubitemid 29162475)
40. Teng B, Murthy KS, Kuemmerle JF, Grider JR, Sase K, Michel T, Makhlouf GM. Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 275: G342-G351, 1998. (Pubitemid 28390072)
41. Van Assche G, Depoortere I, de Vos R, Geboes K, Janssens JJ, Collins SM, Peeters TL. Region-specific antiproliferative effect of VIP and PACAP-(1-38) on rabbit enteric smooth muscle. Am J Physiol Gastrointest Liver Physiol 276: G303-G310, 1999. (Pubitemid 29063629)
42. Van Crombruggen K, Van Nassauw L, Demetter P, Cuvelier C, Timmermans JP, Lefebvre RA. Influence of soluble guanylate cyclase inhibition on inflammation and motility disturbances in DSS-induced colitis. Eur J Pharmacol 579: 337-349, 2008.
43. Van Geldre LA, Lefebvre RA. Interaction of NO and VIP in gastrointestinal smooth muscle relaxation. Curr Pharm Des 10: 2483-2497, 2004.
44. Vento P, Kiviluoto T, Jarvinen HJ, Soinila S. Changes in distribution of three isoforms of nitric oxide synthase in ulcerative colitis. Scand J Gastroenterol 36: 180-189, 2001.
45. Wells RW, Blennerhassett MG. Persistent and selective effects of inflammation on smooth muscle cell contractility in rat colitis. Pflügers Arch 448: 515-524, 2004.
46. Wells RW, Blennerhassett MG. Divergent changes to muscarinic and serotonergic signalling following colitis. Gut 54: 1699-1706, 2005.